Uncategorized
Bio-Tissue Announces Study that Demonstrates Cryopreserved Amniotic Membrane Graft Reduces Recurrence After Pterygium Surgery
MIAMI--(BUSINESS WIRE)--Bio-Tissue, Inc., a business unit of TissueTech, Inc., announced today study findings, published in Cornea, 2017, show that the use of cryopreserved amniotic membrane reduces recurrence rates after pterygium surgery. In this retrospective review, 556 eyes representing 535 patients (291 males 244 females), who had pterygium excision (527 primary, 29 recurrent) were treated with adjunctive cryopreserved amniotic membrane (Amniograft®, Bio-Tissue, Inc. Miami FL). After 17.3